SMILES string
O1[C@@H]([C@@H]([C@H]([C@H]([C@H]1CO)O)O)O)O
InChI
1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3+,4+,5-,6+/m1/s1
InChI key
WQZGKKKJIJFFOK-PHYPRBDBSA-N
grade
pharmaceutical primary standard
API family
galactose
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
Analysis Note
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
Application
Galactose USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
- Guar Gum
- Lactulose Concentrate
- Lactulose Solution
- Ganoderma Lucidum Fruiting Body Powder
- Ganoderma Lucidum Fruiting Body
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
Galactose contains d-galactopyranose (C6H12O6), which is obtained either as one of the products of the metabolism of lactose, a naturally occurring sugar in dairy products, by the digestive enzyme lactase, or from arabinogalactans isolated from a plant-derived source.
Galactose contains d-galactopyranose (C6H12O6), which is obtained either as one of the products of the metabolism of lactose, a naturally occurring sugar in dairy products, by the digestive enzyme lactase, or from arabinogalactans isolated from a plant-derived source.
Other Notes
Sales restrictions may apply.
保管分類
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
1287700-200MG:
jan
Ganoderma Lucidum Fruiting Body Powder
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 40(5), 5008-5008 (2015)
Lactulose Concentrate
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 40(5), 2521-2521 (2016)
Galactose
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 44(5) (2020)
Guar Gum
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 41(2), 5813-5813 (2018)
Michelle P Christie et al.
PloS one, 9(4), e95024-e95024 (2014-04-17)
Glycosylation of biopharmaceuticals can mediate cell specific delivery by targeting carbohydrate receptors. Additionally, glycosylation can improve the physico-chemical (drug-like) properties of peptide based drug candidates. The main purpose of this study was to examine if glycosylation of the peptide enkephalin
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）